NCT03785366: A trial that was reported late by Sebela Women's Health Inc.
This trial has reported, although it was 1624 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03785366 |
|---|---|
| Title | A Randomized, Single-Blind, Comparative Bioavailability Study to Assess the Pharmacokinetic Properties of VeraCept® Intrauterine Contraceptive vs ParaGard® in Healthy, Post-Menarcheal Women |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 17, 2018 |
| Completion date | Dec. 30, 2019 |
| Required reporting date | Dec. 29, 2020, midnight |
| Actual reporting date | June 11, 2025 |
| Date last checked at ClinicalTrials.gov | Sept. 4, 2025 |
| Days late | 1624 |